08

October 8, 2014

Regenerative therapy for DM: SP-1 promotes reprogramming of adult pancreatic ductal cells into α, δ, and β cells via up regulation of Ngn3, 9/October/2014, 5.27 am

A recent study from the Mammalian Genetics Laboratory, Cancer Research UK London Research Institute, Lincoln’s Inn Fields Laboratories, London, United Kingdom; and School of Medicine, King’s College London, London, United […]
October 8, 2014

Interleukin-based Anti-Cancer Stem cell therapy: Interleukin-1β (IL-1β) suppresses the expression of Nucleoplasmin and reprogramming of somatic cells via down regulation of its target gene, 9/October/2014, 5.06 am

The 1989 Nobel prize winner in Physiology/Medicine, Prof. Bishop JM, Qu J and others from G.W. Hooper Foundation, University of California at San Francisco, San Francisco, California 94143, USA has published a research paper in the 11 June […]
October 8, 2014

Natural product-based therapy for Mammary Cancer: Silvestrol, a compound isolated from the fruits of Aglaia foveolata, suppresses Mammary cancer cell migration and invasion via down regulation of Receptor for hyaluronan-mediated motility (RHAMM)/Hyaluronan-mediated motility receptor (HMMR), 8/October/2014, 17.00

A study from the School of Life Sciences, Tsinghua University, Beijing 100084, China shows that “Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.” […]
October 8, 2014

Natural product-based therapy for Human Cancer: Triptolide, a natural compound isolated from Thunder of God vine, suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via up regulation of its target gene, 8/October/2014, 16.54

The 1989 Nobel prize winner in Chemistry, Prof. Thomas R. Cech from the BioFrontiers Institute, USA has published a research paper in the 13 December 2012 Nature (492(7428):285-9; I.F: >35) stating that “The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity.”  This […]